Tag: Patent Review
-
Invention for Light emitting Display, Display Panel, and Driving Method Thereof
Invented by Oh-Kyong Kwon, Samsung Display Co Ltd The market for Light Emitting Display (LED), Display Panel, and Driving Method Thereof has witnessed significant growth in recent years. With the increasing demand for high-quality displays in various industries such as consumer electronics, automotive, healthcare, and advertising, the market is expected to continue its upward trajectory.…
-
Invention for Organic Light Emitting Display Device and Method for Fabricating the Same
Invented by Byung Hee Kim, Samsung Display Co Ltd The market for Organic Light Emitting Display (OLED) devices has been rapidly growing in recent years, driven by the increasing demand for high-quality, energy-efficient displays in various industries. OLED technology offers numerous advantages over traditional liquid crystal displays (LCDs), including better picture quality, wider viewing angles,…
-
Invention for Antibody-drug conjugates, and their uses
Invented by David M. Goldenberg, Serengulam V. Govindan, Immunomedics Inc The market for Antibody-drug conjugates (ADCs) is rapidly growing, driven by their potential to revolutionize cancer treatment. ADCs are a class of targeted therapies that combine the specificity of monoclonal antibodies with the cytotoxicity of small molecule drugs. This unique combination allows for highly targeted…
-
Invention for Antibody variants
Invented by Herman Waldmann, Lisa K Gilliland, Masahide Tone, Mark R Frewin, Louise Walsh, Oxford University Innovation Ltd The market for antibody variants has been rapidly growing in recent years, driven by the increasing demand for personalized medicine and targeted therapies. Antibodies are proteins produced by the immune system to identify and neutralize foreign substances,…
-
Invention for Combination of ABCG2 Inhibitors with Sacituzumab Govitecan (IMMU-132) Overcomes Resistance to SN-38 for Trop-2 expressing Cancers
Invented by Chien-Hsing Chang, David M. Goldenberg, Immunomedics Inc cancers. The market for combination therapies in cancer treatment is constantly evolving, with researchers and pharmaceutical companies striving to find new ways to overcome resistance and improve patient outcomes. One promising combination that has shown great potential is the use of ABCG2 inhibitors in conjunction with…
-
Invention for Bispecific antibodies that bind to CD38 andCD3
Invented by Matthew Bernett, Seung Chu, Gregory Moore, John Desjarlais, Xencor Inc The market for bispecific antibodies that bind to CD38 and CD3 is rapidly growing, thanks to their potential in treating various types of cancer. CD38 is a cell surface protein that is highly expressed on multiple myeloma cells, while CD3 is a protein…
-
Invention for Inhalable Dry Powders
Invented by Wesley H. Dehaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber, Pulmatrix Operating Co Inc The market for inhalable dry powders has been steadily growing in recent years, driven by advancements in technology and a growing demand for convenient and effective respiratory treatments. Inhalable dry powders offer a non-invasive and user-friendly alternative…
-
Invention for Anti-HER2 antibodies, compositions and formulations
Invented by Mikkel Wandahl Pedersen, Allan Jensen, Per-Johan Meijer, Symphogen AS The market for Anti-HER2 antibodies, compositions, and formulations has been experiencing significant growth in recent years. HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that is overexpressed in certain types of cancer, including breast and gastric cancer. Anti-HER2 antibodies are designed to…
-
Invention for Tyrosine Bioconjugation Through Aqueous Ene-Like Reactions
Invented by Carlos F. Barbas, III, Hitoshi Ban, Julia Gavrilyuk, Scripps Research Institute The market for tyrosine bioconjugation through aqueous ene-like reactions is experiencing significant growth and is poised to expand even further in the coming years. This emerging field of bioconjugation offers numerous opportunities for researchers and companies in the pharmaceutical, biotechnology, and diagnostic…
-
Invention for Trispecific antagonists
Invented by Jackie SHENG, Bo Liu, Gensun Biopharma Inc The market for trispecific antagonists is rapidly expanding, driven by the increasing demand for innovative therapeutic options in various disease areas. Trispecific antagonists are a type of biologic drug that target multiple disease pathways simultaneously, offering the potential for enhanced efficacy and improved patient outcomes. Trispecific…